By Casey Thomson This week’s Twitter Round-Up features an “American Idol-style” selection of research grant winners, the problems facing children in Syria attempting to be vaccinated, and a review of where we stand with current patient health information privacy and security. Michelle Meyer (@MichelleNMeyer) retweeted an article about a newly emerging landmark case in…
By Casey Thomson From policy adoption at the federal level to debate over the health concerns of political figures, this week’s round-up focuses largely on the news for bioethics and health law in the realm of politics. Dan Vorhaus (@genomicslawyer) posted a feature on the history of gene patent litigation and implications for next-generation sequencing technologies….
By Dan Vorhaus (Cross-Posted from Genomics Law Report) Earlier this month, my colleagues John Conley, Robert Cook-Deegan, James Evans and I published a policy article in the European Journal of Human Genetics (EJHG) entitled “The next controversy in genetic testing: clinical data as trade secrets.” The EJHG article is open access so you can read the entire article…
By Dan Vorhaus (Cross-Posted from Genomics Law Report) This morning, Gene By Gene, Ltd. – better known as the parent company of the popular genetic genealogy provider Family Tree DNA – formally announced a corporate reorganization that includes the debut of a new division, DNA DTC. (Apparently the news was also announced earlier this month at the Family Tree DNA Conference, although the company…
[Ed. Note: We’re happy to announce that after a great month of guest blogging, Chris Robertson will be joining Bill of Health as a regular contributor.] By Christopher Robertson The New York Times brings us an interesting story about a new brain scan technology that allows the diagnosis of Alzheimer’s Disease. Below the fold, I…
By Casey Thomson Don’t just read the summaries – check out the tweets themselves! From now on, links to the original tweets will be included in our round-up. Additionally, as a reminder from the last post, retweeting should not be read as an endorsement of or agreement with the content of the original tweet. With…
By Adriana Benedict As of 2008, the NIH Public Access Policy requires “that all investigators funded by the NIH submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final, peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months…
By Casey Thomson [Ed. Note. 11/12/12: Just to be clear, retweeting should not be read as an endorsement of or agreement with the content of the original tweet.] With Election Day now come and gone, our bloggers were tweeting this week about the results, in addition to the greater happenings in health law and ethics….
By Yu-Chi Lyra Kuo Last month, John Gurdon and Shinya Yamanaka were jointly awarded the 2012 Nobel Prize for Medicine for their research on induced pluripotent stem cells (iPSCs). iPSCs are capturing the public imagination as embryonic stem cells did fifteen years ago, but without the controversy surrounding the destruction of embryos: iPSCs can be…
By Casey Thomson [Ed. Note: Several of our bloggers are active on Twitter. In a new feature, we’ll be posting some highlights of their tweets each week so you can stay in the know – or think about following them directly!] Dan Vorhaus (@genomicslawyer) linked to Bloomberg’s article on the current underutilization of…
